Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RESHOT SG CAPSULES is an oral nutraceutical combination developed by Captab Biotec for the management of joint pain and orthopedic conditions, such as osteoarthritis. The formulation contains a synergistic blend of active ingredients, including Collagen Peptide Type-I, Collagen Peptide Type-II, Rosehip Extract, Sodium Hyaluronate, Curcumin Extract, and Chondroitin Sulphate Sodium. Together, these components work to support joint health by promoting cartilage repair, reducing inflammation, and improving joint lubrication and mobility. Collagen peptides and chondroitin sulphate provide the structural building blocks to rebuild cartilage, while sodium hyaluronate acts as a lubricant to reduce friction. Curcumin and rosehip extracts offer natural anti-inflammatory and antioxidant benefits to alleviate joint discomfort.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on RESHOT SG CAPSULES.